Completed OBSERVATIONAL NCT04953338

Mental Health Associations With Vitiligo

The Mental Health Associations With Vitiligo: a Population-based Cohort Study in the UK

Sponsor: Momentum Data

Conditions Adjustment Disorders Anxiety Disorders Depressive Episode Overdose Parasuicide Recurrent Depressive Disorder Self-Harm, Deliberate Social Phobia Substance Abuse Suicide, Attempted Vitiligo

Interventions Exposure of mental health condtion of interest

Updated 6 times since 2021 Last updated: Nov 14, 2025 Started: Jun 18, 2021 Primary completion: Aug 30, 2022 Completion: Oct 21, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04953338, this observational or N/A phase trial focuses on Adjustment Disorders and Anxiety Disorders and remains completed. Sponsored by Momentum Data, it has been updated 6 times since 2021, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed
Sep 2024 — Jan 2026 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed

Status: Active Not Recruiting → Completed
Feb 2022 — Jan 2023 [monthly]

Active Not Recruiting

▶ Show 1 earlier version

Sep 2021 — Feb 2022 [monthly]

Active Not Recruiting

First recorded

Jun 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Momentum Data
Pfizer

Data source: Momentum Data

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom